Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Femme et Homme

| Pays :
Germany
| Organes :
| Spécialités :

Extrait

The purpose of this study is to assess the GLP-1 and non-GLP-1 effects of LAF237 on glucagon secretion, using treatment observations of the overall glycemic response.

Critère d'inclusion

Type 2 Diabetes ,Healthy

Liens

nct
ictrp